121 related articles for article (PubMed ID: 1376194)
1. Pathology of carcinoma of the prostate.
Mostofi FK; Davis CJ; Sesterhenn IA
Cancer; 1992 Jul; 70(1 Suppl):235-53. PubMed ID: 1376194
[TBL] [Abstract][Full Text] [Related]
2. A pathologist's view of prostatic carcinoma.
Mostofi FK; Sesterhenn IA; Davis CJ
Cancer; 1993 Feb; 71(3 Suppl):906-32. PubMed ID: 7679044
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Svanholm H
Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
[TBL] [Abstract][Full Text] [Related]
4. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
Maygarden SJ
Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
[No Abstract] [Full Text] [Related]
5. The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland.
Jones EC; Young RH
Am J Clin Pathol; 1994 Jan; 101(1):48-64. PubMed ID: 7506479
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
Feiner HD; Gonzalez R
Am J Surg Pathol; 1986 Nov; 10(11):765-70. PubMed ID: 2430476
[TBL] [Abstract][Full Text] [Related]
7. Silver staining nucleolar organizer region in prostate cytology.
Bittinger A; von Keitz A; Rüschoff J; Melekos MD
Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar organizer regions in benign and malignant prostatic disease.
Lloyd SN; Johnson CP; Brown IL; Kirk D
Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
10. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
Helpap B
Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
[TBL] [Abstract][Full Text] [Related]
13. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
[TBL] [Abstract][Full Text] [Related]
14. [AGNOR analyses of prostate carcinomas of high and malignancy].
Helpap B; Riede C
Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic problems in prostatic pathology: microglandular lesions and intraductal epithelial proliferations].
Berger N; Borda A
Arch Anat Cytol Pathol; 1996; 44(4):141-59. PubMed ID: 9157823
[TBL] [Abstract][Full Text] [Related]
16. Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario.
Glenski WJ; Malek RS; Myrtle JF; Oesterling JE
Mayo Clin Proc; 1992 Mar; 67(3):249-52. PubMed ID: 1372057
[TBL] [Abstract][Full Text] [Related]
17. [Significance of argyrophil staining for nucleolar organizer regions (AgNORs) to pathologic diagnosis of prostatic adenocarcinoma].
Cao X
Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):232-3. PubMed ID: 9387689
[TBL] [Abstract][Full Text] [Related]
18. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
[TBL] [Abstract][Full Text] [Related]
19. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of prostate carcinoma. Diagnosis and differential diagnosis.
Dhom G
Pathol Res Pract; 1985 Jan; 179(3):277-303. PubMed ID: 2580293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
